Evidence map›Paper›PMID 37359900›Full record

ArticleAdvances in laboratory medicine2023

Impact of COVID-19 pandemic on HbA

Paloma Oliver, Marina Pellicer, Daniel Prieto, Jorge Diaz-Garzon, Roberto Mora, Ileana Tomoiu, Noemi Gonzalez, Atilano Carcavilla, Isabel Gonzalez-Casado, Itsaso Losantos and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Advances in laboratory medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Paloma OliverDepartment of Laboratory Medicine, La Paz University Hospital, Madrid, Spain.ORCID https://orcid.org/0000-0003-0582-7122
Marina PellicerDepartment of Laboratory Medicine, La Paz University Hospital, Madrid, Spain.
Daniel PrietoDepartment of Laboratory Medicine, La Paz University Hospital, Madrid, Spain.
Jorge Diaz-GarzonDepartment of Laboratory Medicine, La Paz University Hospital, Madrid, Spain.
Roberto MoraDepartment of Laboratory Medicine, La Paz University Hospital, Madrid, Spain.
Ileana TomoiuDepartment of Laboratory Medicine, La Paz University Hospital, Madrid, Spain.
Noemi GonzalezDepartment of Endocrinology, La Paz University Hospital, Madrid, Spain.
Atilano CarcavillaDepartment of Pediatric Endocrinology, La Paz University Hospital, Madrid, Spain.
Isabel Gonzalez-CasadoDepartment of Pediatric Endocrinology, La Paz University Hospital, Madrid, Spain.
Itsaso LosantosDepartment of Biostatistics, La Paz University Hospital, Madrid, Spain.
Antonio BuñoDepartment of Laboratory Medicine, La Paz University Hospital, Madrid, Spain.
Pilar Fernandez-CalleDepartment of Laboratory Medicine, La Paz University Hospital, Madrid, Spain.
Hospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Diabetes mellitus intensify the risks and complications related to COVID-19 infection. A major effect of the pandemic has been a drastic reduction of in-person visits. The aim of this study was to evaluate the impact of the COVID-19 pandemic on HbA Methods: Observational retrospective study including patients from pediatric and adult diabetes units was conducted. HbA Results: After the lockdown, the number of HbA Conclusions: Continuous glucose monitoring and a telemedicine have been crucial, even allowing for improvements in HbA

Indexed as

COVID-19diabetes mellitusdiagnostic techniques and procedurestelemedicine

Identifiers

PMID37359900
PMCPMC10197181
OpenAlexW4322493442

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.